Factores asociados con el control glucémico óptimo en pacientes tratados con bomba de insulina y monitorización continua de glucosa en tiempo real

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Avances en Diabetología

• Publication date

  2013-05-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.AVDIAB.2013.04.001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Methods.

  2013cited by this paper
• Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens

  2012cited by this paper
• Standards of Medical Care in Diabetes—2013

  2012cited by this paper
• The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

  2012cited by this paper
• Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study

  2011cited by this paper
• Baseline Predictors of A1C Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Therapy: The STAR 3 Experience

  2011cited by this paper
• Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management

  2010cited by this paper
• STAR 3 Randomized Controlled Trial to Compare Sensor-Augmented Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 1 Diabetes: Research Design, Methods, and Baseline Characteristics of Enrolled Subjects

  2010cited by this paper
• The Impact of Baseline Hemoglobin A1c Levels Prior to Initiation of Pump Therapy on Long-Term Metabolic Control

  2010cited by this paper
• Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

  2010cited by this paper
• Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes

  2009cited by this paper
• Hyperglycemic Crises in Adult Patients With Diabetes

  2009cited by this paper
• Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes

  2009cited by this paper
• Sustained Benefit of Continuous Glucose Monitoring on A1C, Glucose Profiles, and Hypoglycemia in Adults With Type 1 Diabetes

  2009cited by this paper
• Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis

  2008cited by this paper
• JDRF Randomized Clinical Trial to Assess the Efficacy of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes: Research Design and Methods

  2008cited by this paper
• Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients

  2008cited by this paper
• Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

  2008cited by this paper
• Hyperglycemic Crises in Adult Patients With Diabetes

  2006cited by this paper
• Standards of medical care in diabetes.

  2006cited by this paper
• Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

  2006cited by this paper
• Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.

  2006cited by this paper
• Postprandial hyperglycemia and diabetes complications: is it time to treat?

  2005cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• Hyperglycemic crises in patients with diabetes mellitus.

  2003cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper

• Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data

  2024cites this paper
• Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up.

  2021cites this paper
• Virtual training on the hybrid close loop system in people with type 1 diabetes (T1D) during the COVID-19 pandemic

  2021cites this paper
• Glycemic Control and Hypoglycemia in Patients Treated with Insulin Pump Therapy: An Observational Study

  2020cites this paper
• Part II: Subcutaneous insulin infusion devices

  2020cites this paper
• Real-world effectiveness and safety of sensor-augmented insulin pump therapy in adults with type 1 diabetes: Long-term follow-up.

  2020cites this paper
• Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security

  2019cites this paper
• Patient Values and Preferences Regarding Continuous Subcutaneous Insulin Infusion and Artificial Pancreas in Adults with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Data

  2019cites this paper
• Hypertension and Diabetes : A Latent Problem in Colombia

  2018cites this paper
• Variabilidad glucémica determinada por monitorización continua de glucosa y su aplicación clínica

  2018cites this paper
• Socio-demographic and clinical characteristics of type 1 diabetes patients associated with emergency room visits and hospitalizations in Mexico

  2018cites this paper
• Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes

  2017cites this paper
• Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia.

  2016cites this paper
• Clinical Outcomes After 1 Year of Augmented Insulin Pump Therapy in Patients with Diabetes in a Specialized Diabetes Center in Medellín, Colombia

  2016cites this paper
• Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia

  2016cites this paper
• Tiempo promedio del efecto máximo de la insulina análoga en la glucemia postprandial y factores relacionados

  2016cites this paper
• Beneficios clínicos y económicos de la terapia con bomba de insulina integrada a sistema de monitoreo continuo de glucosa en los pacientes diabéticos tipo 1 en Colombia

  2016cites this paper
• An Epidemiologic Analysis of Diabetes in Colombia.

  2015cites this paper
• Caracterización epidemiológica de pacientes diabéticos en terapia con infusión subcutánea continua de insulina y monitorización continua de glucosa en tiempo real

  2015cites this paper
• Epidemiological characterization of diabetic patients on therapy with continuous subcutaneous insulin infusion and continuous glucose monitoring in real time

  2015cites this paper
• Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia (cid:2)

  year unknowninfluential citation